Skip to main content
. 2017 Jan 6;12(1):e0169331. doi: 10.1371/journal.pone.0169331

Fig 7. Activation of farnesoid X receptor acts as a central molecular switch in intestinal IRI to decrease inflammation and protect intestinal barrier integrity with subsequent prevention of bacterial translocation.

Fig 7

IRI: Ischemia reperfusion injury; FXR: Farnesoid X receptor. (Continuous line in case of an increased/stimulatory effect; dashed line in case of a decreased/inhibitory effect.)